000			02021 a2200553 4500
005			20250515045052.0
264		0	_c20080129
008			200801s 0 0 eng d
022			_a1094-5539
024	7		_a10.1016/j.pupt.2006.09.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aBeier, Jutta
245	0	0	_aSafety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. _h[electronic resource]
260			_bPulmonary pharmacology & therapeutics _c2007
300			_a740-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdrenergic beta-Agonists _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aElectrocardiography
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aForced Expiratory Volume _xdrug effects
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHumans
650	0	4	_aIndans _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNebulizers and Vaporizers
650	0	4	_aPotassium _xblood
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdrug therapy
650	0	4	_aQuinolones _xadministration & dosage
650	0	4	_aSeverity of Illness Index
650	0	4	_aTime Factors
700	1		_aChanez, Pascal
700	1		_aMartinot, Jean-Benoit
700	1		_aSchreurs, A J M
700	1		_aTkácová, Ruzena
700	1		_aBao, Weibin
700	1		_aJack, Damon
700	1		_aHiggins, Mark
773	0		_tPulmonary pharmacology & therapeutics _gvol. 20 _gno. 6 _gp. 740-9
856	4	0	_uhttps://doi.org/10.1016/j.pupt.2006.09.001 _zAvailable from publisher's website
999			_c16661332 _d16661332